Reduce the high cost of administering site payments and give sites confidence.
This white paper summarizes a discussion with George Kourtsounis, Senior Director for Clinical Trial Contracts and Grants at Bristol Myers Squibb; Casey Orvin, Chief Commercial Officer at CenExel Centers of Excellence; and Jim DiCesare, Senior Director of Study Operations for IQVIA Clinical Trial Payments, a third-party site payments provider that operates independently of IQVIA's contract research organization (CRO).
Reduce the high cost of administering site payments and give sites confidence.
Increase transparency, improve communications and reduce administrative burden for all clinical trial stakeholders.
Ease the burden on your sites and make it easier and more appealing for patients to enroll and remain engaged.
Combine data science, technology, and analytics driven by artificial intelligence to support new efficiencies and business insights -- without additional capital investment.